Theresa Ahrens

2015	PhD thesis, Albert-Ludwigs-University of Freiburg
2012 - 2015	PhD student in the lab of Prof. Dr. Silke Laßmann, Institute of Pathology, University Freiburg Medical Centre
2011 - 2012	PhD student in the lab of Dr. Meike Burger, Department of Haematology and Oncology, University Freiburg Medical Centre
2011	Diploma thesis in Molecular Medicine, Albert-Ludwigs-University of Freiburg
2006 - 2011	Study of Molecular Medicine, Albert-Ludwigs-University of Freiburg

Publications

• Ahrens T.D., Timme S., Ostendorp J., Bogatyreva L., Hoeppner J., Hopt U.T., Hauschke D., Werner M. and Lassmann S. (2016) Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity. Lab Invest 96, 307-316.
• Ahrens T.D., Werner M. and Lassmann S. (2014) Epigenetics in esophageal cancers. Cell Tissue Res 356, 643-655
• Krohn A*, Ahrens T*, Yalcin A, Plones T, Wehrle J, Taromi S, et al. Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes. PloS one. 2014;9(6):e100249. PubMed PMID: 24959847. * authors contributed equally to this work
• Tholen S, Biniossek ML, Gansz M, Ahrens TD, Schlimpert M, Kizhakkedathu JN, et al. Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis. Cellular and molecular life sciences : CMLS. 2014 Mar;71(5):899-916. PubMed PMID: 23811845.
• Ahrens TD, Timme S, Hoeppner J, Ostendorp J, Hembach S, Follo M, Hopt UT, Werner M, Busch H, Boerries M and Lassmann S. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Epigenetics. 2015;10(5):431-445.